CEO
Novartis exec designated as new CEO after Jimenez announces retirement
September 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Novartis, a, joe jimenez, phar, pharma, pharmaceuticals
Novartis has announced that its Chief Executive, Joe Jimenez, is set to retire next year. In his place, Vasant Narasimhan …
Alexion leadership uncertainty ends as ex-Baxalta CEO steps in
March 28, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alexion, CEO
Alexion had been left in leadership limbo for the beginning of the year, as former CEO and CFO left under …
Hard times continue for Valeant as ex-CEO investigated for fraud
November 1, 2016Manufacturing and Production CEO, Valeant, Valeant Pharmaceuticals, accounting, fraud
Valeant Pharmaceuticals continues to have a tough time after Bloomsberg broke the story of how former CEO J. Michael Pearson …
Concordia founder resigns and will step down once replacement found
October 25, 2016Manufacturing and Production CEO, Concordia, Mark Thompson, Valeant
Concordia International Corp., the Ontario-based company, has announced that its founder, Chairman and Chief Executive Officer, Mark Thompson, will leave …
Allergan CEO outlines ‘social contract with patients’
September 7, 2016Research and Development, Sales and Marketing Allergan, Brent Saunders, CEO, blog
Highlighting a recent shift in the priorities of the pharmaceutical industry, Allergan CEO and president Brent Saunders has outlined a …
Grünenthal chief executive Eric-Paul Pâques to retire; new CEO named
June 7, 2016CEO, Grünenthal Group, appointment
Germany-based Grünenthal Group on Tuesday named Gabriel Baertschi its chief executive officer effective October 1, 2016. He succeeds Eric-Paul Pâques who will retire at the end of …
Sanofi sends letter to Medivation board; claims shareholders want takeover
May 5, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Medivation, Sanofi, board, brandicourt, hostile, shareholders, takeover
The CEO of Sanofi has issued a strongly worded letter to the board at Medivation, indicating that shareholders support their …
Valeant names Joseph Papa as new chief executive officer
April 25, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Chairman, Valeant, joseph papa, new, new ceo, papa, pearson
Valeant Pharmaceuticals has announced that Joseph C. Papa will succeed Michael Pearson as chairman and chief executive officer of the …
KaloBios announces new affordable pricing model, refuses to engage in “price gouging”
April 12, 2016Manufacturing and Production, Sales and Marketing CEO, Drug pricing, KaloBios, Martin Shkreli, Shkreli, affordable, price gouging, price model, responsible
Price gouging has become synonymous with drug costs in the US, with the infamous Martin Shkreli and troubled Valeant becoming …
Cambridge Epigenetix says raised $21 million, appoints Geoff Smith CEO
March 14, 2016Business Services, Sales and Marketing CEGX, CEO, Cambridge Epigenetix, fundraising, genome sequencing
Cambridge Epigenetix (CEGX) on Monday said it has raised about $21 million via Series B financing and named Geoff Smith …
Ariad names Manmeet Soni CFO
March 14, 2016Business Services, Sales and Marketing Ariad, CEO, appointment, boardroom, cfo
Ariad Pharmaceuticals Inc (Nasdaq: ARIA) named Manmeet Soni chief financial officer, effective March 21, 2016, succeeding Edward Fitzgerald. Mr Soni will …
Bayer justifies Brandicourt’s ‘golden handshake’
February 27, 2015Medical Communications, Sales and Marketing Bayer, CEO, Sanofi, dekkers, olivier brandicourt, payments, wages
Bayer has confirmed that Sanofi’s justification for the controversial starter package it is giving to the German firm’s Olivier Brandicourt …
Alzheimer’s drug development ‘must speed up’
November 7, 2013Research and Development, Sales and Marketing Alzheimer's, CEO, drug development
Alzheimer’s drugs cost three times the industry average to produce, according to a new draft report – and the way …
Novartis recognised for efforts in cancer
August 8, 2013Medical Communications, Sales and Marketing Bush, CEO, Cancer, Novartis
Novartis is the first company to earn a global CEO Cancer Gold Standard accreditation by the non-profit organisation CEO Roundtable …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
